CPHI Webinar series – API Manufacturing Trends: Watch Now
If you want to learn more about several key issues likely to affect the API manufacturing sector going forward, tune into this recent CPHI Webinar, which provides the cutting-edge perspective from contract development and manufacturing organisations (CDMOs) operating in this high growth area of the pharmaceutical value chain.
Including presentations from three industry experts, the webinar addresses issues such as buyers’ rationale for purchasing decisions, the barriers to new geographical manufacturing hubs forming, the rise of specialty products within European and US manufacturing and the proliferation of advanced manufacturing complexity in the segment.
Providing an overview of the global API market, Molly Bowman, Editorial Director, Clarivate Analytics said it is estimated to grow to $290 billion by 2026, with most analysts anticipating a recovery from this year forward following a near 7% decline over 2020 due to the coronavirus pandemic.
Addressing the question of whether there are going to be shifts in manufacturing trends towards hubs other than India and China, she said that “if we look at other countries that have local API manufacturing, the sheer volume of manufacturers is nowhere near close to those we see in India and China and there’s likely little indication we’re going to see a massive shift into those.”
Stuart Needleman, Chief Commercial Officer, Piramal Pharma Solutions focused on the API sector’s largest segment, small molecules, and identified some key growth drivers including increasing global API demand especially niche segments such as high-potency APIs driven by a robust oncology pipeline.
He said that despite fast growth in biologics, “small molecules will remain the main driver” for CDMOs, with 36 of the 53 new molecular entities approved in 2020 being small molecules.
“It’s still the most outsourced area and still the most mature area,” he added.
Gianluca Franguelli, Vice President, Global Drug Substance Development, Recipharm, told the audience that novel advanced manufacturing models were driving the small molecule space and that nearly 50% of absolute CDMO market growth between 2019 and 2023 would be driven by small molecule APIs.
“Manufacturing complexity is dramatically increasing not only from a technical standpoint but also environmentally from a safety and regulatory perspective,” he said.
Related News
-
News CPHI Barcelona Speaker Interview: Rare diseases and the microbiome boom
At CPHI Barcelona (24–26 October, 2023) we took the time to catch up with one of our speakers, Rajiv Khatau who gave a presentation on: The Microbiome Boom - Unlocking Potential Through Listening to the Gut and was a panellist on:&... -
News CPHI Barcelona 2023 – the Product Innovation sessions: tired of leaking softgels?
Learn how to improve softgel seams and process efficacy from GELITA's presentation in the Product Innovation theatre from the Content hall at CPHI Barcelona in October 2023. -
News How to Commercialise an Advanced Therapy: Connect to Frankfurt on-demand
In this Connect to Frankfurt session, Andrea Zobel, Senior Director, Personalized Supply Chain at World Courier (Berlin Germany), Melissa Lattanzi, VP Emerging Therapies at AmerisourceBergen (King of Prussia, USA), and Hans-Peter Scherzer, Customer Suc... -
Sponsored Content CPHI Podcast Series: Key Considerations in Selecting the Right CMO Partner
In this month's episode we hear from Jayna Blake, Senior Project Manager for Technical Programs at Baxter BioPharma Solutions, on key considerations for successful CMO selection. -
News CPHI Podcast Series: Success in healthcare M&A, taking a people-first approach
Global mergers and acquisitions hit an all-time high in 2021, and in the life sciences industry these kinds of deals show no sign of slowing down. -
News CPHI Podcast Series: Connecting the user to your product – Smart packaging for smart devices
Smart devices are revolutionising how we live our lives and changing the shape of the industries adopting them. One such industry is healthcare, where the benefits of context-aware devices and real-time data sharing are having tangible effects on patie... -
News Biomanufacturing Trends – Capacity, Capability and Careers
In this month's edition of the CPHI Webinar Series, experts from BioPlan Associates and NIBRT share insights on key trends impacting the biomanufacturing and bioprocessing sector. -
News CPHI Podcast Series: Orally Dissolving Tablets
In this month’s CPHI podcast, sponsored by Galien Pharma, we focus on the technology behind orally dissolving tablets.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance